We are live on
!
Find out more
BBA
BLB&B Advisors Portfolio holdings
AUM
$2.73B
Turnover
8.25%
1-Year Est. Return
25.76%
This Fund
S&P 500
This Quarter
Est. Return
+6.56%
1 Year Est. Return
+25.76%
3 Year Est. Return
+71.58%
5 Year Est. Return
+74.54%
10 Year Est. Return
+243.21%
AUM
$473M
AUM Growth
+$21.7M
(+4.8%)
Cap. Flow
-$2.9M
Cap. Flow
% of AUM
-0.61%
Top 10 Holdings %
Top 10 Hldgs %
23.78%
Holding
290
New
10
Increased
69
Reduced
150
Closed
20
Avg Time Held
2
years
Top 10 Avg Time Held
1.8
years
Top 20 Avg Time Held
1.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.79M |
| 2 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$1.62M |
| 3 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$1.34M |
| 4 |
iShares Core S&P Small-Cap ETF
IJR
|
+$1.27M |
| 5 |
Schwab US Mid-Cap ETF
SCHM
|
+$1.06M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco S&P MidCap 400 Revenue ETF
RWK
|
+$1.97M |
| 2 |
Invesco S&P SmallCap 600 Revenue ETF
RWJ
|
+$1.65M |
| 3 |
Vanguard Morningstar Large-Cap ETF
VV
|
+$1.5M |
| 4 |
ExxonMobil
XOM
|
+$1.09M |
| 5 |
Invesco S&P 500 Revenue ETF
RWL
|
+$863K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 17.43% |
| 2 | Technology | 14.1% |
| 3 | Healthcare | 13.57% |
| 4 | Industrials | 13.44% |
| 5 | Consumer Staples | 8.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Intel
INTC
$504B
| $14.5M | 3.07% |
421,485
-6,316
| -1% | -$213K |
2013 Q2
10 quarters
|
|
2
GE Aerospace
GE
$324B
| $14M | 2.97% |
94,110
-4,017
| -4% | -$571K |
2013 Q2
10 quarters
|
|
|
3
ExxonMobil
XOM
$718B
| $13M | 2.75% |
166,926
-13,610
| -8% | -$1.09M |
2013 Q2
10 quarters
|
|
4
Johnson & Johnson
JNJ
$610B
| $12.5M | 2.65% |
122,002
-610
| -0.5% | -$61.3K |
2013 Q2
10 quarters
|
|
5
Procter & Gamble
PG
$365B
| $10.9M | 2.31% |
137,823
+4,149
| +3% | +$317K |
2013 Q2
10 quarters
|
|
6
Microsoft
MSFT
$4.01T
| $10.6M | 2.23% |
190,156
-8,495
| -4% | -$447K |
2013 Q2
10 quarters
|
|
7
Verizon
VZ
$184B
| $9.99M | 2.11% |
216,229
-4,531
| -2% | -$206K |
2013 Q2
10 quarters
|
|
8
IBM
IBM
$221B
| $9.55M | 2.02% |
72,563
-2,881
| -4% | -$387K |
2013 Q2
10 quarters
|
|
|
9
Vanguard FTSE Emerging Markets ETF
VWO
$124B
| $9.04M | 1.91% |
276,381
+38,926
| +16% | +$1.34M |
2013 Q2
10 quarters
|
|
10
AT&T
T
$161B
| $8.31M | 1.76% |
319,786
-8,088
| -2% | -$205K |
2013 Q2
10 quarters
|
|
11
3M
MMM
$85.3B
| $7.96M | 1.68% |
63,212
+1,119
| +2% | +$144K |
2013 Q2
10 quarters
|
|
12
Pfizer
PFE
$168B
| $7.74M | 1.64% |
252,719
-3,717
| -1% | -$117K |
2013 Q2
10 quarters
|
|
13
Corning
GLW
$119B
| $7.69M | 1.63% |
420,711
+717
| +0.2% | +$13K |
2013 Q2
10 quarters
|
|
14
JPMorgan Chase
JPM
$891B
| $7.39M | 1.56% |
111,897
+7,970
| +8% | +$519K |
2013 Q2
10 quarters
|
|
|
15
Vanguard FTSE Developed Markets ETF
VEA
$228B
| $7M | 1.48% |
190,491
+43,120
| +29% | +$1.62M |
2013 Q4
8 quarters
|
|
16
Chevron
CVX
$430B
| $6.13M | 1.3% |
68,130
+189
| +0.3% | +$17K |
2013 Q2
10 quarters
|
|
17
PPL Corp
PPL
$25.9B
| $6.04M | 1.28% |
176,908
-643
| -0.4% | -$21.7K |
2013 Q2
10 quarters
|
|
18
Merck
MRK
$358B
| $5.68M | 1.2% |
112,722
+434
| +0.4% | +$21.9K |
2013 Q2
10 quarters
|
|
19
Bristol-Myers Squibb
BMY
$124B
| $5.67M | 1.2% |
82,474
-4,533
| -5% | -$300K |
2013 Q2
10 quarters
|
|
20
DELISTED
Du Pont De Nemours E I
DD
| $5.56M | 1.17% |
83,443
-2,803
| -3% | -$178K |
2013 Q2
10 quarters
|
|
21
Cisco
CSCO
$433B
| $5.32M | 1.12% |
195,956
+828
| +0.4% | +$22.8K |
2013 Q2
10 quarters
|
|
22
PNC Financial Services
PNC
$85.7B
| $5.25M | 1.11% |
55,026
+2,941
| +6% | +$273K |
2013 Q2
10 quarters
|
|
23
Apple
AAPL
$4.99T
| $5.18M | 1.1% |
196,980
+23,980
| +14% | +$685K |
2013 Q2
10 quarters
|
|
24
Vanguard Morningstar Mid-Cap ETF
VO
$107B
| $5M | 1.06% |
166,696
-19,348
| -10% | -$590K |
2013 Q2
10 quarters
|
|
25
Johnson Controls International
JCI
$89.4B
| $4.89M | 1.03% |
118,148
+7,244
| +7% | +$328K |
2013 Q2
10 quarters
|
|
Similar funds
MAS
ACM
CIAS
LIM
SIG
AGA
GXJ
TAM
BLB&B Advisors's Q4 2015 Portfolio in Review
As of Q4 2015, BLB&B Advisors held 290 positions worth $473M, up 4.8% from $451M the previous quarter. Its ten largest holdings account for 24% of the portfolio.
BLB&B Advisors's Q4 2015 filing shows 10 new, 69 increased, 150 reduced and 20 closed positions. Its largest new stake was Commerce Bancshares: 33,132 shares worth $865K. The largest sale was Invesco S&P MidCap 400 Revenue ETF, an estimated $1.97M.
By sector, the portfolio is most concentrated in Miscellaneous at 17% of assets, down from 18% a quarter earlier, followed by Technology and Healthcare.
- BLB&B Advisors's largest Q4 2015 buy was Commerce Bancshares: 33,132 shares worth $865K.
- BLB&B Advisors added most to State Street SPDR S&P 500 ETF Trust in Q4 2015, an estimated $2.79M increase.
- BLB&B Advisors's biggest Q4 2015 reduction was Vanguard Morningstar Large-Cap ETF, cutting an estimated $1.5M.
- BLB&B Advisors fully exited Invesco S&P MidCap 400 Revenue ETF in Q4 2015, selling an estimated $1.97M.
- BLB&B Advisors's ten largest holdings make up 24% of its $473M portfolio in Q4 2015.
- BLB&B Advisors opened 10 new positions and closed 20 in Q4 2015.
- BLB&B Advisors's portfolio value rose 4.8% quarter-over-quarter to $473M.
Based on BLB&B Advisors's 13F filing for Q4 2015, filed 15 Jan 2016.